55
Participants
Start Date
May 24, 2022
Primary Completion Date
February 2, 2024
Study Completion Date
February 2, 2024
Chronocort
Over-encapsulated hydrocortisone modified-release capsule for oral administration.
Cortef
Over-encapsulated hydrocortisone immediate-release tablet for oral administration.
Placebo
Matching placebo
Diurnal Investigational Site in Caen, Caen
Diurnal Investigational Site in Toulouse (Children's Hospital), Toulouse
Diurnal Investigational Site in Toulouse, Toulouse
Diurnal Investigational Site in Jacksonville, Jacksonville
Diurnal Investigational Site in Pessac, Bordeaux
Diurnal Investigational Site in Michigan, Ann Arbor
Diurnal Investigational Site in Iowa, Iowa City
Diurnal Investigational Site in Milwaukee, Milwaukee
Diurnal Investigational Site in Rochester, Rochester
Diurnal Investigational Site in Bron, Lyon
Diurnal Investigational Site in Dallas, Dallas
Diurnal Investigational Site in Paris, Paris
Diurnal Investigational Site in Nevada, Las Vegas
Diurnal Investigational Site in Los Angeles, Los Angeles
Diurnal Investigational Site in Orange, Orange
Diurnal Investigational Site in Seattle, Seattle
Diurnal Investigational Site in Maryland, Bethesda
Diurnal Investigational Site in Asahi-ku, Yokohama
Diurnal Investigational Site in Yushima, Bunkyō-Ku
Diurnal Investigational Site in Okura, Setagaya-Ku
Diurnal Investigational Site in Toyama, Shinjuku-Ku
Neurocrine UK Limited
INDUSTRY